Pfizer Concludes Coronavirus Vaccine Trial And Will Seek FDA Approval
A final analysis of Pfizer's clinical trial found its coronavirus vaccine is 95% effective. The drugmaker will now seek the Food and Drug Administration's approval for emergency use of the vaccine.